| 产品描述: | 对雌激素相关受体ERRβ和ERRγ有选择性的激动剂;Agonist selective for estrogen-related receptors ERRβ and ERRγ;DY131(GSK 9089)是ERRβ和ERRγ选择性激动剂,对ERRα,ERα和ERβ的活性极低。;DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ; displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ |
| 体内研究: |
DY131 (5 μg/kg;皮下注射;每隔一天;持续 12 天) 处理增加 P450 侧链裂解 (P450scc)、StAR 和 HMGCoA 还原酶 (HMGCR),同时降低激素敏感性脂肪酶 (HSL) 表达。 |
| 参考文献: |
1. Yu S, et al. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer Res. 2007;67(10):4904-14. 2. Donna D. Yu, Barry Marc Forman. Identification of an agonist ligand for estrogen-related receptors ERRβ/γ. Bioorganic & Medicinal Chemistry Letters. 2005,15(5): 1311-1313. 3. Wang Y, et al. Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation . ACS Chem Biol. 2012,15;7(6):1040-8. 4. Yamamoto T, et al. Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer. Int J Gynecol Cancer. 2012;22(9):1509-16. 5. A Pacwa, et al. Interplay between estrogen-related receptors and steroidogenesis-controlling molecules in adrenals. In vivo and in vitro study. Acta Histochem. 2018 Jul;120(5):456-467. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.212 ml |
16.058 ml |
32.115 ml |
| 5 mM |
0.642 ml |
3.212 ml |
6.423 ml |
| 10 mM |
0.321 ml |
1.606 ml |
3.212 ml |
| 50 mM |
0.064 ml |
0.321 ml |
0.642 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |